Radiofarmaceutisch
Pharma
ATMP Cel- en gentherapie
Services
Waarschuwing! De inhoud van deze pagina is alleen beschikbaar in de volgende talen: Engels
The Comecer Group has been growing steadily since its beginnings in the early 1970′s.
| 1970′s | Comecer was founded as a technology supplier for the Italian Nuclear Agency (ANI). Partnership with ENEA and Ansaldo are established developing multiple prototypes and innovative products. |
| 1980′s | Due to the 1987 nuclear energy development stop in Italy, Comecer moved its competence and know-how to the medical field (safety solutions for nuclear medicine labs). |
| 1990′s | Acquisition and mastering of the stainless steel manufacturing technology with wide application on Comecer products. |
| 2000′s | Development of key agreements with research and technology partners for customized nuclear medicine product development. |
| 2010 | Since the late’00s Comecer has become a reference partner for designing, manufacturing, and the offer of high tech solutions focusing on improving accuracy and safety in the nuclear medicine and isolation technology sectors. |
| 2011 | Fondo Italiano di Investimento has reached an agreement for the entry with a minority stake in Comecer. |
| 2012 | Acquisition by Comecer S.p.a. of Veenstra Instrumenten B.V. (Netherlands) and Brita Trade (Czech Republic). |
| 2015 | The operator Principia SGR acquired the minority stake in the company, taking over the Italian Investment Fund with the medium-term objective of listing the company on the Stock Exchange. |
| 2019 | Comecer S.p.A. becomes part of ATS Automation Tooling Systems Inc., an industry-leading automation solutions provider. |
| 2021 | Comecer S.p.A acquires DF Siena, a company specialized in the supply of specialized production equipment and systems mainly aimed at the pharmaceutical market, with a growing presence also in other markets, including the food market. |
